| 000 | 00853 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517145837.0 | ||
| 264 | 0 | _c20190619 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1523-5866 | ||
| 024 | 7 |
_a10.1093/neuonc/nox035 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHuang, Raymond | |
| 245 | 0 | 0 |
_aResponse assessment in high-grade glioma: tumor volume as endpoint. _h[electronic resource] |
| 260 |
_bNeuro-oncology _c06 2017 |
||
| 300 |
_a744-745 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aBevacizumab |
| 650 | 0 | 4 | _aBrain Neoplasms |
| 650 | 0 | 4 | _aGlioblastoma |
| 650 | 0 | 4 | _aGlioma |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aTumor Burden |
| 773 | 0 |
_tNeuro-oncology _gvol. 19 _gno. 6 _gp. 744-745 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/neuonc/nox035 _zAvailable from publisher's website |
| 999 |
_c27051741 _d27051741 |
||